Detalhe da pesquisa
1.
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.
Lancet Oncol
; 25(4): 439-454, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547891
2.
Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.
Future Oncol
; 20(6): 297-306, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916501
3.
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
Oncologist
; 2022 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35536733
4.
New Immuno-oncology Targets and Resistance Mechanisms.
Curr Treat Options Oncol
; 23(9): 1201-1218, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35980521
5.
A qualitative study of interactions with oncologists among patients with advanced lung cancer.
Support Care Cancer
; 30(11): 9049-9055, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948849
6.
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.
Lancet Oncol
; 22(7): 959-969, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34118197
7.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29466156
8.
Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.
Cancer
; 124(13): 2841-2849, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669181
9.
Correction to: A qualitative study of interactions with oncologists among patients with advanced lung cancer.
Support Care Cancer
; 31(9): 534, 2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615810
10.
Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.
Oncologist
; 22(7): 786-796, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28487464
11.
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
Lancet Oncol
; 17(7): 984-993, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283860
12.
Combination of stereotactic ablative body radiation with targeted therapies.
Lancet Oncol
; 15(10): e426-34, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25186046
13.
Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative.
Int J Cancer
; 135(8): 1869-83, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24599876
14.
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer.
Adv Ther
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38698170
15.
Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC.
J Thorac Oncol
; 19(3): 500-506, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012986
16.
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Non-Squamous EGFR-Wildtype NSCLC in the Phase 2 LUMINOSITY Trial.
J Clin Oncol
; : JCO2400720, 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38843488
17.
Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4).
J Thorac Oncol
; 18(8): 1031-1041, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36958688
18.
Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart Review.
Clin Lung Cancer
; 24(7): 641-650.e2, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741716
19.
HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies.
Cancers (Basel)
; 14(17)2022 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077691
20.
Systemic Treatment Patterns and Outcomes in Patients With EGFR Mutated Non-small Cell Lung Cancer and Leptomeningeal Disease.
Clin Lung Cancer
; 23(5): 446-455, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35610115